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Abstract Glial cells missing (GCM) proteins form a small
family of transcriptional regulators involved in di¡erent devel-
opmental processes. They contain a DNA-binding domain that
is highly conserved from £ies to mice and humans and consists
of approximately 150 residues. The GCM domain of the mouse
GCM homolog a was expressed in bacteria. Extended X-ray
absorption ¢ne structure and particle-induced X-ray emission
analysis techniques showed the presence of two Zn atoms with
four-fold coordination and cysteine/histidine residues as ligands.
Zn atoms can be removed from the GCM domain by the Zn
chelator phenanthroline only under denaturating conditions.
This suggests that the Zn ions are buried in the interior of the
GCM domain and that their removal abolishes DNA-binding
because it impairs the structure of the GCM domain. Our re-
sults de¢ne the GCM domain as a new type of Zn-coordinating,
sequence-speci¢c DNA-binding domain. / 2002 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
The gcm gene family codes for a small family of eukaryotic
transcription factors [1]. The ¢rst family member was discov-
ered in Drosophila melanogaster where it functions as a switch
between neuronal and glial cell fate during early development
of the nervous system [2^4]. The two murine homologs
mGCMa and mGCMb do not appear to be involved in glia
cell development. Mouse GCMa is required for proper for-
mation of the labyrinth in the developing placenta where the
exchange of nutrients and gases between mother and embryo
takes place [5,6]. Mouse GCMb is essential for parathyroid
gland development [7]. In both cases, targeted deletion leads
to loss of respective tissue.
Drosophila gcm, and mouse gcma and gcmb genes encode
transcription factors with lengths of 504, 436 and 504 amino
acid residues, respectively. They all contain a DNA-binding
domain of about 150 amino acid residues at the N-terminal
end and one or two trans-activation domains in the C-termi-
nal half of the molecule. Sequence homology between di¡er-
ent species is restricted to the DNA-binding domain. This
GCM domain is su⁄cient for DNA binding. In vitro binding
site selection experiments using Drosophila GCM de¢ned an
octameric motif with the sequence 5P-ATGCGGGT-3P [8,9],
which is also recognized by the murine homologs mGCMa
and mGCMb with apparently similar speci¢cities [10,11].
The same target sequences are also present in potential
GCM target genes [8,12]. GCM binds as a monomer to its
DNA-binding site, which is rather unusual as most transcrip-
tion factors bind their target sites as dimers. The GCM do-
main contains a large number of cysteine and histidine resi-
dues, which had led to the suggestion that the GCM domain
is a Zn-containing DNA-binding domain. However, the se-
quence signature of the cysteine and histidine residues does
not resemble any classical Zn-binding DNA-binding domains
like Zn ¢ngers or Zn clusters [13]. In addition Zn-ion chela-
tors which e¡ectively abolish DNA-binding of Zn-¢nger pro-
teins had failed to show any e¡ect on DNA-binding of the
GCM domain, which had led to the conclusion that in GCM
domains an important structural role of Zn ions is unlikely
[10].
Alanine-scan mutagenesis of Arg, Lys, His and Cys residues
had given some insight into residues critical for DNA-binding
of GCM [10]. Further insight into the function of GCM do-
mains has been hampered due to the lack of structural infor-
mation. We have started an extensive biophysical character-
ization of the GCM domain including co-crystallization
experiments with DNA oligonucleotides as a prerequisite for
an X-ray analysis. Di¡erent crystal forms of GCM/DNA
complexes were obtained and a crystallographic analysis is
currently in progress. X-ray £uorescence spectroscopy of ini-
tial GCM/DNA co-crystals unexpectedly revealed the pres-
ence of Zn ions in the GCM domain that was further explored
by extended X-ray absorption ¢ne structure (EXAFS) and
microPIXE (particle-induced X-ray emission) analyses. These
experiments unambiguously demonstrate that the GCM do-
main contains two Zn ions tightly coordinated by cysteine and
histidine residues and required for its DNA-binding activity.
Our results de¢ne the GCM domain as a new class of Zn-
containing, sequence-speci¢c DNA-binding domain.
2. Materials and methods
2.1. Expression and puri¢cation of the GCM domain of mGCMa
The gene coding for residues 1^174 of murine GCMa was cloned
into plasmid pET28a (Novagen) which contains a N-terminal His-tag
followed by a thrombin cleavage site. For expression we used Esche-
richia coli strain BL21(DE3) codon+ (Stratagene). After induction by
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0.5 mM IPTG cells were grown for 4 h at 37‡C. For cell lysis 8 g of
bacterial wet paste was sonicated in 30 ml lysis bu¡er (500 mM NaCl,
20 mM Tris^HCl (pH 7.9), 1 mM L-mercaptoethanol) and subse-
quently centrifuged for 90 min at 250 000Ug. The clear supernatant
was incubated for about 1 h with 3 ml Ni-NTA resin (Qiagen). Sub-
sequently the resin was transferred into a column and washed with 20
column volumes of washing bu¡ers (20 mM Tris (pH 7.9), 8 mM
imidazole, 1 M NaCl for 10 volumes, 500 mM NaCl for 5 volumes,
250 mM NaCl for the last 5 volumes) and eluted in a bu¡er contain-
ing 250 mM imidazole, 200 mM NaCl and 20 mM Tris (pH 7.9). The
fractions containing the protein were pooled together and dialyzed
against a bu¡er containing 20 mM Tris (pH 7.9), 200 mM NaCl
and 10 mM dithiothreitol (DTT). The histidine tag was cleaved over-
night with human plasma thrombin (Sigma) using 1 U per 0.15 mg of
protein at room temperature. After cleavage the protein still contains
six residues preceeding the mGCMa sequence. As a ¢nal step the
protein was applied to a Superdex-75 column (Pharmacia) equilibrat-
ed with 200 mM NaCl, 20 mM Tris (pH 7.9), 10 mM DTT. The
pooled fractions were ¢nally concentrated to 13 mg/ml.
2.2. EXAFS experiment
GCM-domain solution of 0.6 mM (13 mg/ml) in 200 mM NaCl, 20
mM sodium phosphate (pH 7.9), 10 mM DTT was ¢lled into sample
holders covered with Kapton windows, frozen in liquid nitrogen and
kept at 30 K during the experiment. X-ray absorption spectra at the
Zn K-edge were gathered in £uorescence mode at the EMBL bending
magnet beamline D2 (DESY, Hamburg, Germany) using a Si(111)
double crystal monochromator, a focussing mirror and a 13 element
Ge solid-state detector. Energy calibration was achieved by Bragg
re£ections of a static Si(220) crystal in back re£ection geometry
[14]. Data was reduced with the EXPROG software package (C.
Hermes and H.F. Noilting, EMBL-Hamburg) with EO;Zn = 9660 eV.
Analysis of the EXAFS spectrum with constrained model re¢nement
was performed with EXCURV98 [15]. Ligand types and coordination
numbers were varied manually; the software re¢ned distances, Debye^
Waller factors and the Fermi energy o¡set.
2.3. microPIXE analysis
To determine the exact stoichiometry of the Zn ions present in the
GCM domain we used PIXE analysis, where a strong proton beam
induces X-ray £uorescence characteristic for the elements present in
the sample. In proteins of known sequence the number of sulfurs in
cysteines and methionine residues can be used as an internal calibra-
tion. In this analysis sodium and chlorine had to be removed from the
sample (both these elements give overlapping X-ray emission signals
with the sulfur), as well as any other source of sulfur than the protein
(namely DTT or L-mercaptoethanol). Hence, the protein bu¡er, 200
mM NaCl, 20 mM Tris (pH 7.9), 10 mM DTT, was exchanged for a
solution containing 200 mM KBr and 20 mM potassium phosphate
(pH 6.5) using a centricon-10 (Millipore). The scanning proton mi-
croprobe developed at Oxford University possesses a sensitivity of 1^
10 ppm per weight and a proton beam diameter of 1 Wm [16]. For the
experiment 1 Wl of protein solution was dried on a Kimfoil ¢lm.
Subsequently, the sulfur signal was used to localize the protein in
the dried drop and this region of the drop was scanned for 15 min
in the proton beam integrating the signal in this region.
2.4. Circular dichroism (CD)
For the CD experiments and X-ray £uorescence experiments the
protein was incubated for 20 min with 5 mM 1,10-phenanthroline
prior to gel ¢ltration. The gel ¢ltration column was equilibrated
with 200 mM KF and 20 mM ammonium phosphate (pH 6.5) suitable
for CD spectroscopy. The CD experiment was performed in a solution
containing 0.4 mg/ml GCM-domain protein in a 0.1 cm thick cuvette
(200 Wl) using a Jasco J-810 spectrometer (sensitivity settings 100
millidegrees, data pitch 0.5 nm). Wavelength scans were performed
from 180 to 250 nm at a speed of 50 nm/min. The signal to noise ratio
was increased by averaging 10 spectra. The secondary structure con-
tent was calculated using Jasco spectrometer software. The protein
melting curve was obtained with 2 mg/ml GCM-domain solution at
the minimum of 224 nm using a temperature ramp from 10 to 95‡C
with a ramping speed of 20‡C/h.
2.5. Electrophoretic mobility shift assay (EMSA) experiments
EMSAs were performed with 5^30 ng bacterially expressed, puri¢ed
GCM domain and 0.5 ng of 32P-labeled probe containing the con-
sensus GCM-binding site as described [10]. In some samples, the pu-
ri¢ed GCM domain was incubated for 20 min at room temperature
with 1^5 mM 1,10-phenanthroline prior to the addition of probe. In
denaturation/renaturation experiments, the GCM domain was incu-
bated for 2 min at 90‡C in the presence or absence of 1,10-phenan-
throline, followed by immediate placement on ice or slow cooling to
4‡C at a rate of 0.1‡C per 10 s. Samples were loaded onto native 4%
polyacrylamide gels and electrophoresed in 0.5UTBE (45 mM Tris,
45 mM boric acid, 1 mM EDTA, pH 8.3). After drying, gels were
exposed overnight to X-ray ¢lm.
3. Results
3.1. Protein expression and puri¢cation
The DNA-binding domain of mGCMa was previously ex-
pressed in eukaryotic cells [10]. We now show that the GCM
domain can be also expressed in E. coli and subsequently
puri¢ed to high purity and concentrated to about 13 mg/ml.
Using size exclusion chromatography the protein elutes as a
single, symmetric peak with an elution volume corresponding
to a molecular mass of 20 kDa (calculated mass: 20 996 Da),
which suggests that the protein is a monomer in solution. This
result is consistent with the observation that the GCM do-
main binds its DNA-target sites as a monomer [10]. The pu-
ri¢cation protocol yields about 1 mg of pure protein from 1 g
of bacterial wet paste that binds speci¢cally to its target sites
as con¢rmed by EMSA. The possibility to express the GCM
domain as a soluble, monomeric and active protein, which can
be concentrated to high concentrations and co-crystallized
with DNA oligonucleotides, con¢rms the GCM domain as a
stable, independent folding domain and makes it a prime can-
didate for further structural studies. Co-crystals with DNA
duplexes containing the target site have been obtained and
an X-ray analysis is currently in progress.
3.2. EXAFS and microPIXE analysis of the GCM domain
reveals the presence of two Zn ions
The primary sequence of the GCM domain contains a large
number of conserved cysteine and histidine residues often in-
volved in the coordination of Zn ions (Fig. 1). However, the
cysteine/histidine pattern in the primary sequence of mGCMa
H-X12-H-X8-C-X5-C-X3-C-X14-C-X11-C-X24-C-X8-C-X2-H-
X23-H-X2-H does in no way resemble classical Zn ¢ngers or
Zn2Cys6 binuclear clusters. Furthermore treatment with 1,10-
phenanthroline and EDTA as chelating agents did not inter-
fere with DNA binding [10]. Whether Zn is contained within
the GCM domain therefore requires further investigation.
An X-ray £uorescence spectrum recorded at the MAD
beamline BM14 at the ESRF showed a clear absorption signal
at a wavelength of 1.28 AV (9.7 KeV) indicating the presence of
Zn in GCM/DNA co-crystals. To further characterize the Zn-
binding site an EXAFS experiment was performed at beam-
line D2 at the EMBL Outstation, Hamburg, Germany. EX-
AFS experiments provide information on the type and num-
ber of surrounding ligands. However, if several Zn sites are
present in the same molecule EXAFS does not discriminate
the di¡erent binding sites but rather integrates them. EXAFS
does therefore not determine the exact number of Zn ions
bound per protein molecule. The Zn K-edge EXAFS spec-
trum was obtained in good quality up to k=15.5 AV 31 (Fig.
2). The double peak between 4.0 and 5.0 AV 31 indicates multi-
ple backscattering by imidazole rings ligating the Zn atom.
Model re¢nement revealed the presence of three coordinating
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sulfur atoms at 2.31W 0.01 AV and one coordinating imidazole
group at 2.03W 0.02 AV (Fig. 2, Table 1). This model has an R-
factor of 36.2%. The metal ligand distances are in good agree-
ment with distances found for four-fold coordinated structur-
al Zn sites in proteins and model complexes [17]. The average
Zn coordination of GCM therefore consists of one ligating
histidine residue and three ligating cysteine or methionine res-
idues. Since cysteine is far more abundant in Zn coordination
than methionine [18], the coordinating sulfur atoms represent
most likely cysteine residues.
The number of Zn atoms per protein molecule was deter-
mined using a microPIXE analysis (Table 2). The analysis
showed the presence of 1.7 ( W 0.15) Zn atoms per protein
molecule using as internal standard the 12 sulfurs present in
seven cysteines and ¢ve methionines. The estimated error of
the Zn content results from the errors in the sulfur and Zn
concentration and from the error in ¢tting the thickness of the
sample (E. Garman, personal communication). The analysis
also showed no detectable amounts of other metals present in
the protein sample.
Taken both microPIXE and EXAFS results together we
conclude that the GCM domain contains two Zn sites, either
both with a 3Cys/1His coordination or one site with a 4Cys
and the second with a 2Cys/2His coordination. According to
Fig. 1. Conserved cysteine and histidine residues in the GCM do-
main. A: Sequence alignment of the GCM domain of murine
GCMa with murine GCMb and D. melanogaster GCM. Conserved
and conservatively substituted residues are marked with asterisks
and dots, respectively. Conserved cysteine and histidine residues in
the GCM domain are depicted on yellow and red background. B:
Sequence signatures of Zn-coordinating, sequence-speci¢c DNA-
binding domains with known 3D-structures.
Fig. 2. EXAFS spectrum of mGCMa. A: EXAFS spectrum, B: Fourier transformation. Data at the Zn K-edge was gathered as described in
Section 2. Experimental data are represented by thin lines, the theoretical spectrum of the model given in Table 1 is represented by thick, gray
lines. M(k) : EXAFS amplitude, rP : metal-ligand distance corrected for ¢rst shell phase shifts, a.u.: arbitrary units.
Table 1
Average Zn coordination of the GCM domain of mGCMa
Ligand Atoma N r (AV ) 2c2 (AV 2)
Hisb N1 1 2.03 (2) 0.006 (1)
C2 1 2.95 (2) 0.018 (1)
C2 1 3.07 (2) 0.018 (1)
N3 1 4.09 (2) 0.018 (1)
C3 1 4.18 (2) 0.018 (1)
S1 3 2.31 (1) 0.006 (1)
N : coordination number, r : mean interatomic distance to Zn center,
2c2 : Debye^Waller factor. R-factor: 36.2%, Fermi energy o¡set:
37.9 eV. Numbers in brackets indicate the uncertainty of the last
digit. The R-factor for the EXAFS data is de¢ned as:
R ¼
X
N
i
1
c i
ðMM expi ðkÞ3Mmodeli ðkÞMÞU100%
with
1
c i
¼
X
j
kðjÞn
kðjÞnM exp ðjÞM
aAtoms with equal indices were grouped together for the collective
re¢nement of the Debye^Waller factors and the distance to the met-
al center in the case of the ¢rst coordination shell.
bHistidine is represented by an imidazole group. Its structure was
taken from the EXCURV98 software and used for rigid body re-
¢nement.
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the microPIXE analysis one site could be fully occupied and
the second occupied by 70% or both sites partially occupied.
Our results identify six cysteines of seven present in the GCM
domain of mGCMa as direct Zn ligands. A model containing
three partially occupied Zn atoms can be excluded because of
the limited number of cysteine residues.
3.3. Zn ions of the GCM domain can be only removed under
denaturating conditions
EXAFS and microPIXE analysis show the presence of two
Zn atoms in the GCM domain. Unlike other Zn-containing
transcription factors, treatment of native GCM with the high-
a⁄nity Zn chelator 1,10-phenanthroline did not abolish nor
reduce DNA-binding activity in EMSA when tested at ¢nal
concentrations of both 1 mM and 5 mM (Fig. 4A, and data
not shown).
To further investigate this apparent discrepancy the GCM
domain was incubated for 20 min with 5 mM 1,10-phenan-
throline before the last gel ¢ltration step (see Section 2). After
Table 2
microPIXE spectrum analysis
Element Conc. by weight (ppm or %) Error estimate ( W%)
Al 17.6% 0
P 10.4% 0
S 3.0% 1
K 31.0% 0
Ca 2517.0 ppm 29
Mn 81.0 ppm 57
Fe 186.0 ppm 40
Zn 84522.0 ppm 5
Br 44.6% 1
For the above listed elements intensities of the X-ray £uorescence at
the K-edge were extracted by peak ¢tting and integration of the
counts in the peaks to obtain the weight in part per million (ppm)
or as percentage. Phosphate was present in the protein bu¡er solu-
tion. Potassium was present both in the bu¡er and in the matrix.
Bromine was present in the matrix, the L-edge of bromine overlaps
with the aluminum K-edge resulting in an aluminum signal even in
its absence.
Fig. 3. Comparison of GCM-domain protein before and after 1,10-
phenanthroline treatment. A: Fluorescence absorption spectra of
GCM-domain/DNA co-crystals recorded at ESRF beamlines BM14
and protein solutions (0.1 mM, 2 mg/ml) with and without 1,10-
phenanthroline treatment recorded at ESRF beamline ID29. The
concentration of the protein in the crystal is approximately 25 mM.
The deviations from the theoretical value of the Zn absorption at
9.659 KeV (1.2836 AV ) are most likely caused by calibration errors
of the monochromators. Measurement performed on beamline ID29
were multiplied by a factor of 5 to compare them with the spectrum
of the crystal recorded at BM14. B: CD spectrum of mGCMa
GCM domain treated with 5 mM 1,10-phenanthroline compared
with untreated sample. Both samples were recorded at 0.4 mg/ml
protein concentration and no normalization was applied. C: Ther-
mal stability of mGCMa GCM domain treated with 5 mM 1,10-
phenanthroline compared with untreated sample. The CD melting
curve was taken at 224 nm corresponding to the second minimum
of spectrum B. No normalization was applied to both curves.
Fig. 4. Zn dependent DNA-binding of the GCM domain. A: Bind-
ing of increasing amounts of the murine GCMa domain (5, 10, 20
and 30 ng, indicated by triangles) to its cognate radiolabeled site
was analyzed by EMSA after preincubation in the absence (3) or
presence (+) of 1 mM 1,10-phenanthroline. B: EMSA of the murine
GCMa domain (20 ng) on its binding site following various pre-
treatment protocols. Protein was kept at room temperature (RT) or
was heated to 90‡C in the presence (+) or absence (3) of 1 mM
1,10-phenanthroline followed by fast (straight arrow) or slow (bent
arrow) cooling to 4‡C. FP, free probe with no protein added.
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this treatment we used X-ray £uorescence to test the presence
of Zn in the GCM domain. In addition, we compared the CD
spectra of native GCM-domain protein and protein treated
with phenanthroline and the melting curves of the two sam-
ples. The results of the X-ray £uorescence experiments are
presented in Fig. 3A. Protein treated with phenanthroline
and native protein show very similar X-ray £uorescence spec-
tra, which indicates that under our experimental conditions
phenanthroline is not able to remove the Zn ions. The CD
spectrum of native GCM protein (Fig. 3B) is typical for a
protein with high L-sheet content of 37% and an K-helix con-
tent of 10%. The melting temperature for the native protein
was calculated to 41‡C (Fig. 3C). As expected from the X-ray
£uorescence experiments no di¡erence of the CD spectra and
thermal melting curves between native and phenanthroline-
treated proteins can be observed.
In further experiments, the GCM domain was heat-dena-
tured in the presence and absence of 1,10-phenanthroline and
renatured by slow cooling or immediately put on ice. As evi-
dent from EMSAs, the GCM domain was still able to bind to
its octameric consensus motif after this treatment provided
that 1,10-phenanthroline was absent during heating. However,
when 1,10-phenanthroline was present during denaturation,
no DNA-binding activity was recovered (Fig. 4B) suggesting
that 1,10-phenanthroline e¡ectively removes Zn ions from a
denatured GCM domain, thereby interfering with proper re-
folding.
4. Discussion
Our EXAFS and microPIXE analyses show the presence of
two Zn ions in the GCM domain which are tetrahedrally
coordinated by cysteine and histidine residues. This is an un-
expected result because in earlier experiments the strong metal
chelators 1,10-phenanthroline and EDTA showed no e¡ect on
the DNA-binding activity of mGCMa which made any im-
portant role of Zn ions in the GCM domain unlikely [10]. The
two Zn ions present in the GCM domain coordinate six out of
the seven conserved cysteines and two out of ¢ve conserved
histidines (Fig. 1A). Results of earlier alanine substitution
experiments indicate which cysteine residues might coordinate
the Zn ions [10]. Alanine substitutions of all cysteine residues
except residue Cys101 in the GCM domain of mGCMa led to
strongly reduced expression levels in transiently transfected
COS cells, whereas alanine mutation of Cys101 only changed
the redox sensitivity of the DNA-binding activity but did not
a¡ect its expression level. It is therefore likely that Cys101 is
the only cysteine residue not directly involved in Zn binding.
Among the histidine residues, only alanine substitution of
residues His152 and His154 led to reduced GCMa expression,
which makes both residues prime candidates for the Zn-ligat-
ing histidine residues.
Given the presence of Zn ions in the GCM domain, the
resistance of its DNA-binding activity to Zn chelators can
be either a consequence of the tight binding of the Zn ions
by the protein or the absence of any role of the Zn ions in the
DNA-binding activity (or even both). Our X-ray £uorescence
and CD spectroscopy experiments demonstrate that the Zn
ions are indeed tightly bound and that at room temperature
phenanthroline is not able to remove the Zn ions from the
GCM domain. Such tight binding of the Zn ions is also sup-
ported by the observation that both Zn positions are almost
fully occupied in the bacterially expressed GCM domain de-
spite the facts that no Zn ions were present during bacterial
growth and puri¢cation and that large amounts of DTT were
used during the last steps of the puri¢cation. Only under heat-
denaturating conditions as demonstrated by our EMSA ex-
periments the GCM domain becomes sensitive to metal che-
lators and treatment with 1,10-phenanthroline can abolish
DNA binding (Fig. 4). This indicates that the Zn ions in
the GCM domain are deeply buried in the protein core where
they appear to play an essential, structural role in the native
protein or during the folding process. The removal of the Zn
ions impairs the structure of the GCM domain and therefore
abolishes DNA binding. An important structural role of the
Zn ions in the GCM domain is also supported by a recent
survey: accordingly, in most DNA-binding domains Zn ions
play structural roles where they are generally four-fold coor-
dinated with cysteine and histidine residues as observed in the
GCM domain. In Zn-containing enzymes Zn ions show more
£exible coordination geometries with coordination numbers
varying between four and six and with residues His, Asp
and Glu as preferred Zn ligands [17]. The tight binding of
Zn ions by the GCM domain di¡ers from the situation in
the Zn-¢nger transcription factor Krox-24 where treatment
with phenanthroline at room temperature is su⁄cient to abol-
ish DNA binding [10]. Similarly, in the tumor suppressor p53
a Zn ion in tetrahedral coordination ligated by three cysteines
and one histidine can be removed by a Zn chelator. Metal-
lothioneines can also modulate the transcriptional activity of
p53 and it has therefore been suggested that Zn ions regulate
the p53 DNA-binding a⁄nity in vivo [19]. For the GCM
domain the strong binding of the Zn ions and the drastic
treatment required for their removal makes any regulatory
role unlikely.
Our results add the GCM domain as an additional proto-
type of Zn-coordinating, sequence-speci¢c DNA-binding do-
main. For ¢ve di¡erent classes structural information is avail-
able [20,21]. The classical Zn-¢nger proteins of the Cys2His2-
type form the largest class of Zn-containing DNA-binding
domains with more than 700 members being identi¢ed in
the human genome. Other classes of Zn-containing DNA-
binding domains are the Gal4-type transcription factors where
six cysteines and two Zn ions form a bi-nuclear Zn2Cys6
cluster, the transcription factors of the nuclear receptor family
with two tandem Zn-binding modules, the GATA transcrip-
tion factors with a Zn-binding module resembling the N-ter-
minal Zn-binding module of the nuclear receptor DNA-bind-
ing domain and the tumor suppressor p53. The di¡erent
classes can be generally recognized by relatively simple Cys/
His sequence signatures corresponding to the ability of the Zn
ion to stabilize small, discrete protein domains except for p53
and the GCM domain where no such simple signatures can be
derived (Fig. 1B). It has been argued that Zn is used to sta-
bilize domains, which are not su⁄ciently large to form a sta-
ble hydrophobic core. However, this argument is probably
less valid for p53 and the GCM domain where the DNA-
binding domains comprise 200 and 150 residues, respectively.
In p53 the Zn ion has acquired an additional regulatory role,
whereas the exact role of the two Zn ions in the GCM domain
has to await a detailed crystallographic analysis.
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